These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2043936)

  • 41. Induction of rat gastric damage by the endothelium-derived peptide, endothelin.
    Whittle BJ; Esplugues JV
    Br J Pharmacol; 1988 Dec; 95(4):1011-3. PubMed ID: 3064853
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of pancreatic polypeptides and neuropeptide Y on the rat vas deferens.
    Ohhashi T; Jacobowitz DM
    Peptides; 1983; 4(3):381-6. PubMed ID: 6688871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5'-triphosphate and noradrenaline as sympathetic cotransmitters in the rat arterial mesenteric bed.
    Donoso MV; Steiner M; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1997 Aug; 282(2):691-8. PubMed ID: 9262332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Splanchnic and renal vasoconstriction during neuropeptide Y infusion in healthy humans.
    Ahlborg G; Weitzberg E; Lundberg JM
    Clin Physiol; 1992 Mar; 12(2):145-53. PubMed ID: 1582134
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The actions of the peptides, neuropeptide Y and peptide YY, on the vascular and capsular smooth muscle of the isolated, blood-perfused spleen of the dog.
    Corder R; Lowry PJ; Withrington PG
    Br J Pharmacol; 1987 Apr; 90(4):785-90. PubMed ID: 3580708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
    Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
    Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuropeptide Y is a potent vasoconstrictor and a cardiodepressant in rat.
    Zukowska-Grojec Z; Marks ES; Haass M
    Am J Physiol; 1987 Nov; 253(5 Pt 2):H1234-9. PubMed ID: 3688263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo receptor characterization of neuropeptide Y-induced effects in consecutive vascular sections of cat skeletal muscle.
    Ekelund U; Erlinge D
    Br J Pharmacol; 1997 Feb; 120(3):387-92. PubMed ID: 9031740
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NPY is not a primary mediator of the acute thyroid blood flow response to sympathetic nerve stimulation.
    Dey M; Michalkiewicz M; Huffman L; Hedge GA
    Am J Physiol; 1993 Jul; 265(1 Pt 1):E24-30. PubMed ID: 8338150
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of neuropeptide Y on myocardial contractility and coronary blood flow.
    Awad SJ; Einstein R; Potter EK; Richardson DP
    Br J Pharmacol; 1991 Sep; 104(1):195-201. PubMed ID: 1838493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
    Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
    Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuropeptide Y and peptide YY inhibit excitatory synaptic transmission in the rat dorsal motor nucleus of the vagus.
    Browning KN; Travagli RA
    J Physiol; 2003 Jun; 549(Pt 3):775-85. PubMed ID: 12730340
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of the contractile effect of neuropeptide Y in feline cerebral arteries.
    Edvinsson L
    Acta Physiol Scand; 1985 Sep; 125(1):33-41. PubMed ID: 2864784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of d-myo-inositol-1,2,6-trisphosphate on neuropeptide Y-induced potentiation of various vasoconstrictor agents in the rat.
    Sun XY; Edvinsson L; Hedner T
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1147-52. PubMed ID: 1602380
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of neuropeptide Y-induced augmentation of noradrenaline-induced vasoconstriction by D-myo-inositol 1,2,6-trisphosphate in the rat mesenteric arterial bed.
    Ralevic V; Edvinsson L; Burnstock G
    Acta Physiol Scand; 1994 Jul; 151(3):309-17. PubMed ID: 7976403
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lack of norepinephrine--neuropeptide Y interactions in the hypothalamic control of cardiovascular regulation in urethane-anesthetized rats.
    Petrie JP; Jones DL
    Can J Physiol Pharmacol; 1993; 71(5-6):326-34. PubMed ID: 8402398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of neuropeptide Y and noradrenaline on uterine artery blood pressure and blood flow velocity in the pregnant guinea-pig.
    Fried G; Thoresen M
    Regul Pept; 1990 Mar; 28(1):1-9. PubMed ID: 2326502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of neuropeptide Y on the blood pressure response to various vasoconstrictor agents.
    Aubert JF; Waeber B; Rossier B; Geering K; Nussberger J; Brunner HR
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1088-92. PubMed ID: 2843627
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modulatory action of adenosine on gastric function and ethanol-induced mucosal damage in rats.
    Cho CH; Ogle CW
    Dig Dis Sci; 1990 Nov; 35(11):1334-9. PubMed ID: 2226094
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of pancreatic polypeptide family peptides on feeding and learning behavior in mice.
    Nakajima M; Inui A; Teranishi A; Miura M; Hirosue Y; Okita M; Himori N; Baba S; Kasuga M
    J Pharmacol Exp Ther; 1994 Feb; 268(2):1010-4. PubMed ID: 8113957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.